U.S. markets close in 5 minutes
  • S&P 500

    4,120.79
    -19.27 (-0.47%)
     
  • Dow 30

    32,763.67
    -68.87 (-0.21%)
     
  • Nasdaq

    12,493.66
    -150.80 (-1.19%)
     
  • Russell 2000

    1,908.70
    -32.51 (-1.67%)
     
  • Crude Oil

    90.65
    -0.11 (-0.12%)
     
  • Gold

    1,811.40
    +6.20 (+0.34%)
     
  • Silver

    20.49
    -0.12 (-0.60%)
     
  • EUR/USD

    1.0210
    +0.0016 (+0.15%)
     
  • 10-Yr Bond

    2.7970
    +0.0320 (+1.16%)
     
  • GBP/USD

    1.2071
    -0.0011 (-0.09%)
     
  • USD/JPY

    135.1440
    +0.1710 (+0.13%)
     
  • BTC-USD

    23,088.17
    -846.79 (-3.54%)
     
  • CMC Crypto 200

    536.01
    -21.34 (-3.83%)
     
  • FTSE 100

    7,488.15
    +5.78 (+0.08%)
     
  • Nikkei 225

    27,999.96
    -249.28 (-0.88%)
     

Lannett Company, inc (LCI) Q1 2022 Earnings Call Transcript

·20 min read
Lannett Company, inc (LCI) Q1 2022 Earnings Call Transcript
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Good afternoon, everyone, and thank you for joining us today to discuss Lannett Company's fiscal 2022 first quarter financial results. On the call today are Tim Crew, Chief Executive Officer; John Kozlowski, the company's Chief Financial Officer; Maureen Cavanaugh, our Chief Commercial Operations Officer; and Steve Lehrer, who leads our biosimilar insulin initiatives.